MacKie, R.M.

melanoma patient interferon cancer trial survival study group treatment observation incidence stage adjuvant number analysis lymph density hospital metastasis-free survival interferon group pegylated observation group eortc table factor disease recurrence-free survival cutaneou signi exposure cutaneous melanoma oncology event therapy result oncol center month adjuvant therapy thickness phase effect tumour recurrence-free dendritic cells randomised prognostic lymph nodes e ffect sentinel europe dendritic university dc-lamp death research article ulceration ifn-a ficant diagnosis country response nodal risk factors melanoma risk european population involvement resected period nodal involvement value female metastasis-free increase duration mortality eggermont sentinel lymph nodes